Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 16, 2026

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

Moving the needle: Optimizing classification for glioma.

Roel G W Verhaak¹

¹Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. rverhaak@mdanderson.org.

Science Translational Medicine

|August 5, 2016

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Community perspectives on the return of research results and ownership of data and specimens for brain tumor genomic research.

SSM. Qualitative research in health·2026

Same author

Acquired genetic and cell-state changes in IDH-mutant glioma progression.

Nature·2026

Same author

Dordaviprone for Diffuse Midline Glioma: A Landmark Approval or a Premature Step?

Neuro-oncology·2026

Same author

TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas.

Cell reports. Medicine·2026

Same author

Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a Phase 0/1 trial of recurrent high-grade glioma.

Neuro-oncology·2025

Same author

Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Neuro-oncology·2025

Same journal

Erratum for the Research Article "Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer".

Science translational medicine·2026

Same journal

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Science translational medicine·2026

Same journal

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026

Same journal

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026

Same journal

KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models.

Science translational medicine·2026

Same journal

Hypoxia-driven T cell-macrophage-stromal cross-talk sustains fibrosis in preclinical models of cutaneous chronic graft-versus-host disease.

Science translational medicine·2026

See all related articles

Genomic markers offer objective data to improve cancer sample classification. This approach complements traditional histopathology methods for more accurate diagnoses.

Area of Science:

Oncology
Genomics
Pathology

Background:

Histopathology is the traditional method for cancer diagnosis.
Genomic markers offer a new avenue for cancer classification.
Integrating genomic data can enhance diagnostic accuracy.

Purpose of the Study:

To explore the utility of genomic markers in cancer classification.
To evaluate how genomic markers can augment histopathology.

Main Methods:

Analysis of genomic markers in cancer samples.
Comparison with traditional histopathology findings.

Main Results:

Genomic markers provide unbiased information for cancer classification.
The integration of genomic data enhances traditional histopathology.

More Related Videos

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Related Experiment Videos

Last Updated: Mar 16, 2026

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Conclusions:

Genomic markers are valuable tools for improving cancer diagnosis.
Combining genomic and histopathology approaches offers a more robust classification system.